HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates

One of the most significant breakthroughs in cancer research has been the identification of persistent infection with certain human papillomaviruses (HPV) genotypes as the cause of cervical cancer. Since then, a range of diagnostic and therapeutic methods has been developed based on this discovery....

Full description

Saved in:
Bibliographic Details
Main Authors: Emilia Włoszek, Kamila Krupa, Eliza Skrok, Michał Piotr Budzik, Andrzej Deptała, Anna Badowska-Kozakiewicz
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/32/3/122
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850089693613391872
author Emilia Włoszek
Kamila Krupa
Eliza Skrok
Michał Piotr Budzik
Andrzej Deptała
Anna Badowska-Kozakiewicz
author_facet Emilia Włoszek
Kamila Krupa
Eliza Skrok
Michał Piotr Budzik
Andrzej Deptała
Anna Badowska-Kozakiewicz
author_sort Emilia Włoszek
collection DOAJ
description One of the most significant breakthroughs in cancer research has been the identification of persistent infection with certain human papillomaviruses (HPV) genotypes as the cause of cervical cancer. Since then, a range of diagnostic and therapeutic methods has been developed based on this discovery. This article aims to describe the latest updates in the biology, prevention, and treatment of HPV-related cervical cancer. The current state of knowledge regarding vaccinations, diagnostic tests, and cervical cancer therapies is presented. The latest WHO guidelines on vaccinations are presented, as well as announcements of upcoming changes. The final part of the article summarizes promising new diagnostic and treatment methods, as well as perspectives and the latest research findings on self-administered diagnostic tests, the use of therapeutic vaccines, and circulating cell-free DNA in diagnosis. Despite the significant progress made in recent years, the strategy based on vaccination and testing remains the cornerstone in the fight against HPV-related cervical cancer.
format Article
id doaj-art-309700d24b2a4dedbc47ff500e1d6780
institution DOAJ
issn 1198-0052
1718-7729
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj-art-309700d24b2a4dedbc47ff500e1d67802025-08-20T02:42:42ZengMDPI AGCurrent Oncology1198-00521718-77292025-02-0132312210.3390/curroncol32030122HPV and Cervical Cancer—Biology, Prevention, and Treatment UpdatesEmilia Włoszek0Kamila Krupa1Eliza Skrok2Michał Piotr Budzik3Andrzej Deptała4Anna Badowska-Kozakiewicz5Students’ Scientific Organization of Cancer Cell Biology, Department of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandStudents’ Scientific Organization of Cancer Cell Biology, Department of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandStudents’ Scientific Organization of Cancer Cell Biology, Department of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandDepartment of Oncology Propaedeutics, Medical University of Warsaw, 02-091 Warsaw, PolandOne of the most significant breakthroughs in cancer research has been the identification of persistent infection with certain human papillomaviruses (HPV) genotypes as the cause of cervical cancer. Since then, a range of diagnostic and therapeutic methods has been developed based on this discovery. This article aims to describe the latest updates in the biology, prevention, and treatment of HPV-related cervical cancer. The current state of knowledge regarding vaccinations, diagnostic tests, and cervical cancer therapies is presented. The latest WHO guidelines on vaccinations are presented, as well as announcements of upcoming changes. The final part of the article summarizes promising new diagnostic and treatment methods, as well as perspectives and the latest research findings on self-administered diagnostic tests, the use of therapeutic vaccines, and circulating cell-free DNA in diagnosis. Despite the significant progress made in recent years, the strategy based on vaccination and testing remains the cornerstone in the fight against HPV-related cervical cancer.https://www.mdpi.com/1718-7729/32/3/122human papillomavirusHPVcervical cancervaccinationscreeningsystemic therapy
spellingShingle Emilia Włoszek
Kamila Krupa
Eliza Skrok
Michał Piotr Budzik
Andrzej Deptała
Anna Badowska-Kozakiewicz
HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
Current Oncology
human papillomavirus
HPV
cervical cancer
vaccination
screening
systemic therapy
title HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
title_full HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
title_fullStr HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
title_full_unstemmed HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
title_short HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
title_sort hpv and cervical cancer biology prevention and treatment updates
topic human papillomavirus
HPV
cervical cancer
vaccination
screening
systemic therapy
url https://www.mdpi.com/1718-7729/32/3/122
work_keys_str_mv AT emiliawłoszek hpvandcervicalcancerbiologypreventionandtreatmentupdates
AT kamilakrupa hpvandcervicalcancerbiologypreventionandtreatmentupdates
AT elizaskrok hpvandcervicalcancerbiologypreventionandtreatmentupdates
AT michałpiotrbudzik hpvandcervicalcancerbiologypreventionandtreatmentupdates
AT andrzejdeptała hpvandcervicalcancerbiologypreventionandtreatmentupdates
AT annabadowskakozakiewicz hpvandcervicalcancerbiologypreventionandtreatmentupdates